Berita English News

Pfizer to Exit GSK's Consumer Health Arm After London Listing

Rabu, 01 Juni 2022 | 20:19 WIB
Pfizer to Exit GSK's Consumer Health Arm After London Listing

ILUSTRASI. Pfizer plans to exit its 32% stake in Haleon, a consumer health joint venture with British drugmaker GSK. REUTERS/Matthew Childs

Sumber: Reuters | Editor: Anastasia Lilin Yuliantina

KONTAN.CO.ID - LONDON. Pfizer plans to exit its 32% stake in Haleon, a consumer health joint venture with British drugmaker GSK, after the business lists as an independent company in July. GSK said on Wednesday.

GSK is spinning off Haleon, which makes Sensodyne toothpaste and Advil painkillers, so it can focus on disease prevention and treatment. GSK rejected a 50 billion pound (US$ 63 billion) offer for Haleon last year, saying it undervalued the firm.


Baca juga